Andhra Sugars Ltd

Andhra Sugars Ltd

₹ 113 0.55%
28 Aug - close price
About

Incorporated in 1947, Andhra Sugars Limited is a manufacturer of Sugar, Industrial Alcohol, Chlor Alkali Products, Aspirin, Sulphuric Acid, Liquid & Solid Propellants. It also generates power for captive use [1]

Key Points

Business Segments
Chemicals: The Co produces different chemicals like Aluminium Chloride, Sodium Hypochlorite, Liquid Chlorine etc, which go as basic building blocks to a host of industries like Pharmaceuticals, paper, textiles, pesticides, water treatment etc.
Sugar: The sugar crushing operations commenced in 1952 at Tanuku with a 600 TCD capacity and has increased to 16,000 TCD currently.
Pharma: The Co started commercial production of Aspirin in 1980. Its plant is certified by USFDA, EDQM & WHO. [1]

  • Market Cap 1,532 Cr.
  • Current Price 113
  • High / Low 129 / 92.0
  • Stock P/E 21.6
  • Book Value 117
  • Dividend Yield 1.77 %
  • ROCE 5.73 %
  • ROE 5.06 %
  • Face Value 2.00

Pros

  • Company is almost debt free.
  • Stock is trading at 0.97 times its book value
  • Company has been maintaining a healthy dividend payout of 18.3%

Cons

  • The company has delivered a poor sales growth of 6.59% over past five years.
  • Company has a low return on equity of 11.4% over last 3 years.
  • Earnings include an other income of Rs.73.7 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chlor Alkali / Soda Ash

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
414 471 509 568 660 610 559 539 492 518 451 433 480
356 420 445 479 557 539 493 486 452 490 436 403 469
Operating Profit 58 51 64 89 103 71 66 53 40 28 15 30 11
OPM % 14% 11% 13% 16% 16% 12% 12% 10% 8% 5% 3% 7% 2%
25 36 23 31 13 3 5 8 8 16 12 19 27
Interest 5 3 3 3 1 1 1 1 0 0 1 0 0
Depreciation 15 16 16 17 16 17 17 17 18 19 19 20 19
Profit before tax 62 68 69 101 98 57 54 44 29 25 7 29 19
Tax % 17% 15% 19% 21% 22% 29% 25% 23% 26% 21% -19% 10% 16%
52 58 56 80 76 40 40 34 22 20 9 26 16
EPS in Rs 3.76 4.16 4.08 5.87 5.55 2.88 2.90 2.38 1.55 1.38 0.74 1.87 1.09
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1,232 1,099 1,107 1,258 1,279 1,308 1,376 1,477 1,509 1,962 2,368 1,894 1,882
1,013 946 1,042 1,100 1,060 1,096 1,073 1,199 1,293 1,700 2,060 1,781 1,798
Operating Profit 220 153 65 159 218 212 303 279 216 262 308 113 84
OPM % 18% 14% 6% 13% 17% 16% 22% 19% 14% 13% 13% 6% 4%
-3 6 13 20 26 44 62 44 43 116 25 54 74
Interest 24 22 24 29 27 33 31 29 27 13 4 1 1
Depreciation 51 54 42 56 51 55 55 62 61 64 76 76 76
Profit before tax 142 83 12 93 167 168 278 231 170 300 253 90 80
Tax % 36% 32% 92% 39% 25% 29% 31% 9% 17% 18% 25% 16%
90 57 1 56 125 119 192 211 141 246 191 76 70
EPS in Rs 6.17 3.81 -0.36 3.55 8.96 8.60 14.06 14.99 9.96 17.87 13.72 5.54 5.08
Dividend Payout % 23% 26% -167% 28% 22% 23% 14% 27% 20% 22% 15% 18%
Compounded Sales Growth
10 Years: 6%
5 Years: 7%
3 Years: 8%
TTM: -14%
Compounded Profit Growth
10 Years: 4%
5 Years: -16%
3 Years: -17%
TTM: -49%
Stock Price CAGR
10 Years: 15%
5 Years: 14%
3 Years: 2%
1 Year: 0%
Return on Equity
10 Years: 12%
5 Years: 12%
3 Years: 11%
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 27 27 27 27 27 27 27 27 27 27 27 27
Reserves 609 642 622 756 906 960 1,104 1,126 1,270 1,491 1,514 1,556
279 293 336 274 369 255 301 261 159 55 24 31
484 520 465 358 415 390 427 393 422 466 470 461
Total Liabilities 1,398 1,482 1,449 1,415 1,716 1,632 1,859 1,808 1,879 2,039 2,035 2,075
577 541 527 511 658 650 700 711 716 712 806 813
CWIP 9 26 21 61 30 98 58 32 52 71 125 181
Investments 113 129 114 208 358 261 356 267 366 409 307 317
700 786 787 635 671 623 745 798 745 848 797 764
Total Assets 1,398 1,482 1,449 1,415 1,716 1,632 1,859 1,808 1,879 2,039 2,035 2,075

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
164 89 29 178 245 202 114 181 253 176 286 142
-49 -56 -44 -71 -259 -17 -133 -15 -141 -27 -204 -102
-107 -35 16 -113 24 -175 23 -167 -132 -148 -91 -23
Net Cash Flow 7 -2 2 -6 10 11 4 -1 -21 2 -10 17

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 44 45 48 44 53 49 49 53 53 45 36 36
Inventory Days 212 307 258 200 194 173 282 250 208 171 125 161
Days Payable 12 24 19 18 46 27 28 29 34 33 24 36
Cash Conversion Cycle 244 328 287 227 201 195 304 274 226 182 137 161
Working Capital Days 106 132 146 110 92 95 120 119 105 106 77 115
ROCE % 19% 10% 3% 11% 15% 14% 21% 16% 13% 19% 16% 6%

Shareholding Pattern

Numbers in percentages

4 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
46.92% 46.92% 46.94% 46.94% 46.96% 47.08% 47.08% 47.08% 47.08% 47.08% 47.19% 47.19%
0.00% 0.00% 0.00% 0.00% 3.42% 3.56% 3.52% 3.55% 3.38% 3.28% 3.02% 2.92%
1.75% 2.62% 2.84% 3.24% 0.00% 0.00% 0.00% 0.00% 0.05% 0.00% 0.00% 0.00%
51.33% 50.46% 50.22% 49.82% 49.61% 49.36% 49.40% 49.37% 49.50% 49.64% 49.79% 49.89%
No. of Shareholders 24,93127,72042,95845,00744,92146,08145,91245,09047,14247,85348,79953,406

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents